A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of Life

Completed

Conditions studied: Familial Mediterranean Fever

In brief

A retrospective, non-interventional, single-center study conducted in Spain, based on the collection of data from the medical histories of patients with Familial Mediterranean fever (FMF) diagnosed during childhood from January 2005 to December 2021. Data from the patients' medical records was collected retrospectively, from the time of diagnosis to the current moment of the patient's enrollment in the study. Patients had a minimum follow-up of 3 months after diagnosis.

Key facts

Study ID

NCT06923124

Run by

Novartis Pharmaceuticals

People needed

44

Starts

2023-03-30

Expected to finish

2024-05-28

Last updated by the study team

2025-04-11

Who can join

Age: any, up to 28. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with FMF clinically and/or genetically diagnosed during childhood according to the site's clinical practice.
• Patients with at least 3 months of follow-up from the date of diagnosis, at the time of their enrollment in the study.

You may not qualify if…

• Patients with autoinflammatory disease excluding FMF.
• Patients with recurrent fever of another etiology (infectious, tumor or other).

Where it is running

• Novartis — East Hanover, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.